Professor Emeritus, Infectious DiseasesProfessor Emeritus, Molecular Virology, Immunology and Medical Genetics
Physician-FGP, Infectious Diseases
419 McCampbell Hall
1581 Dodd Drive
Columbus, Ohio 43210
614-293-5666
Michael.Para@osumc.edu
Licenses
- Board certification (61868): American Board of Internal Medicine, 1977 - present
- Board certification (61868): American Board of Internal Medicine, 1980 - present
- MD: license number 35045442: State Medical Board of Ohio, 1980 - present
Special Interests
Dr. Para's clinical interest is in HIV and viral infections in compromised hosts. His research interest is in HIV therapeutics and vaccines, HIV management issues and HIV drug resistance. His recent work focuses on clinical trials of HIV therapeutics and vaccines.
Education
MD: The Ohio State University, 1974
BS: Michigan State University, 1970
Honors
- America's Best Doctors, Best Doctors, Inc., 2008 - present
- America's Best Doctors, Best Doctors, Inc., 2007 - present
- Columbus AIDS Task Force Executive Director's Award, 2004 - present
- Franks and Mary Pomerene Professorship in the Treatment of Infectious Diseases, 2003 - present
- Stonewall Union Columbus President's Award, 2001 - present
- Healthcare Foundation Humanism in Medicine Award, 2001 - present
- Unverfurth Research Award, Department of Internal Medicine, The Ohio State University College of Medicine, 2000 - present
- AIDS Leadership Award, Ohio Department of Health, 1999 - present
- The Ohio State University College of Medicine Alumni Achievement Award, 1999 - present
-
Community Service Award, Columbus Medical Association, 1998 - present
- CATF President's Award, Columbus AIDS Task Force, 1991 - present
- Professor of the Year, The Ohio State University College of Medicine, class of 1989, 1989 - present
- AIDS Service Award, Ohio Department of Health, 1988 - present
- College of Medicine Clinical Teaching Award, College of Medicine, 1987 - present
- Michael Greer Humanitarian Award, Columbus Human Rights Campaign, 1986 - present
- College of Medicine Pre-clinical Teaching Award, College of Medicine, 1986 - present
- Research award, The Ohio State University College of Medicine, Department of Internal Medicine, 1983 - present
- Research fellow, Damon Runyon-Walter Winchell Foundation, 1978 - present
- First place, Landacre Student Research Award, The Ohio State University College of Medicine, 1974 - present
- Department of Internal Medicine House Staff In-patient Teaching Award, 2009
- Department of Internal Medicine House Staff Faculty Award, 2008 - 2009
- Distinguished Physician Award, Department of Internal Medicine, 2008
- Provider Award, second annual Health Care Heroes Award program, 2007 - 2008
- Recipient of Firestone Scholarship, 1966-1970
- Honors College, 1967 - 1970
Professional Activities
- Ohio Department of Health Advisory Committee, Columbus, OH, 1985 - present
- Ohio Department of Health AIDS Drugs Assistance Program - member, Columbus, OH, 1994 - present
- Columbus AIDS Task Force - board member, Columbus, OH, 1997 - 2006
- Ohio Department of Health Hemophilia Advisory Committee - member, Columbus, OH, 1986 - 2003
- Ohio Department of Health - advisor, Columbus, OH, 1981 - 1988
- Columbus HELP Chapter - medical advisor, Columbus, OH, 1981 - 1988
Spear PG, Para MF, Baucke R. "The Fc binding receptor induced by herpes simplex virus i." In The Human Herpes Viruses: Interdisciplinary Prespective. Edited by AJ Nahmias, WR Dowdle, R Schinazi. -. *: Elsevir North Holland, January 1981
Para, MF, Baird, I. "Genital ulcer syndrome." In Sexually Transmitted Diseases. Edited by R Prior and V Spagna. 161-185. New York, NY, US|USA: Marcel Dekker, January 1985
Koletar SL and Para MF. "Mitral Valve Prolapse and Infective Endocarditis." In Mitral Valve Prolapse and Mitral Valve Prolapse Syndrome.. Edited by Boudoulas, H. and Wooley, C.. 275-288. Mount Kisco, NY, US|USA: Futura Publishing Co., January 1988
Para MF. "A man with shortness of breath, weight loss and night sweats.." In Internal Medicine - Case studies. Edited by Bowen & Mazzaferri. 16-32. New York, NY, US|USA: Plenum Publishing, January 1989
Koletar SL and Para MF. "Immunizations." In Principals of Infection and Resistance. Mortensen. Edited by RF, Krier J,. 289-304. Philadelphia, PA, US|USA: Harper and Rowe Publishers, January 1990
Fletcher C, Swindells S, Para M. "Nonnucleoside Analogue Reverse Transcriptase Inhibitors." In Antimicrobial Therapy and Vaccines Volume II Antimicrobial Agents. Edited by Yu V, Edwards G, McKinnon P, Peloquin, Morse, Potoski.. 817-. *: Apple Trees Productions, LLC, January 2005
Para M. "Case 11: 37 Year Old Male with Headach." In Bouncebacks. 153-163. Columbus: Anadem Publishing, January 2006
Para, MF, Baird, I. "Genital ulcer syndrome." In Sexually Transmitted Diseases. Edited by R Prior and V Spagna. 161-185. New York, NY, US|USA: Marcel Dekker, January 1985
Koletar SL and Para MF. "Mitral Valve Prolapse and Infective Endocarditis." In Mitral Valve Prolapse and Mitral Valve Prolapse Syndrome.. Edited by Boudoulas, H. and Wooley, C.. 275-288. Mount Kisco, NY, US|USA: Futura Publishing Co., January 1988
Para MF. "A man with shortness of breath, weight loss and night sweats.." In Internal Medicine - Case studies. Edited by Bowen & Mazzaferri. 16-32. New York, NY, US|USA: Plenum Publishing, January 1989
Koletar SL and Para MF. "Immunizations." In Principals of Infection and Resistance. Mortensen. Edited by RF, Krier J,. 289-304. Philadelphia, PA, US|USA: Harper and Rowe Publishers, January 1990
Fletcher C, Swindells S, Para M. "Nonnucleoside Analogue Reverse Transcriptase Inhibitors." In Antimicrobial Therapy and Vaccines Volume II Antimicrobial Agents. Edited by Yu V, Edwards G, McKinnon P, Peloquin, Morse, Potoski.. 817-. *: Apple Trees Productions, LLC, January 2005
Para M. "Case 11: 37 Year Old Male with Headach." In Bouncebacks. 153-163. Columbus: Anadem Publishing, January 2006
Plouffe JF, Para MF, Hackman B, Webster L and Maher WE. "Nosocomial Legionnaires' disease: Difference in attack rates associated with two strains of Legionella pneumophila serogroup l." The Second International Symposium on Legionella.. (January 1984). 216-218
Para MF, Plouffe JF and Maher WE. "Production of monoclonal antibodies to Legionella pneumophila and the relationship of monoclonal antibody binding to plasmid content." The Second International Symposium on Legionella.. (January 1984). 262-264
Maher WE, Plouffe JF, Para MF. "Plasmid profiles of clinical and environmental isolates of serogroup 1 Legionella pneumophila.." The Second International Symposium on Legionella. (January 1984). 272-274
Fan-Havard ,P; Knudtson, E, J; Kang, S, K; Vasist, L; Jende, J, W; Para, M; Brady, M. "Implementation of pharmaceutical care services in an HIV high-risk pregnancy clinic." In PHARMACOTHERAPY. (October 2002). 1378-1378
Joy, U; Poi, M; Hughes, L; Brady, M, T; Koletar, S, L; Para, M, F; Fan-Havard, P. "Third-trimester maternal toxicity with nevirapine use in pregnancy." In OBSTETRICS AND GYNECOLOGY. (November 2005). 1032-1038
Franco,A; Joy,S,D; Kang,S; Poi,M; Hunkler,J; Brady,M,T; Koletar,S,L; Para,M,F; Fan-Havard,P. "Maternal and newborn outcomes in a multidisciplinary HIV pregnancy program.." In PHARMACOTHERAPY. (October 2005). 1455-1456
Joy, S; Poi, M; Hughes, L; Brady, M; Koletar, S; Para, M; Fan-Havard, P. "Third trimester maternal toxicity with nevirapine use in pregnancy." In JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION. (February 2005). 315A-316A
Para MF, Plouffe JF and Maher WE. "Production of monoclonal antibodies to Legionella pneumophila and the relationship of monoclonal antibody binding to plasmid content." The Second International Symposium on Legionella.. (January 1984). 262-264
Maher WE, Plouffe JF, Para MF. "Plasmid profiles of clinical and environmental isolates of serogroup 1 Legionella pneumophila.." The Second International Symposium on Legionella. (January 1984). 272-274
Fan-Havard ,P; Knudtson, E, J; Kang, S, K; Vasist, L; Jende, J, W; Para, M; Brady, M. "Implementation of pharmaceutical care services in an HIV high-risk pregnancy clinic." In PHARMACOTHERAPY. (October 2002). 1378-1378
Joy, U; Poi, M; Hughes, L; Brady, M, T; Koletar, S, L; Para, M, F; Fan-Havard, P. "Third-trimester maternal toxicity with nevirapine use in pregnancy." In OBSTETRICS AND GYNECOLOGY. (November 2005). 1032-1038
Franco,A; Joy,S,D; Kang,S; Poi,M; Hunkler,J; Brady,M,T; Koletar,S,L; Para,M,F; Fan-Havard,P. "Maternal and newborn outcomes in a multidisciplinary HIV pregnancy program.." In PHARMACOTHERAPY. (October 2005). 1455-1456
Joy, S; Poi, M; Hughes, L; Brady, M; Koletar, S; Para, M; Fan-Havard, P. "Third trimester maternal toxicity with nevirapine use in pregnancy." In JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION. (February 2005). 315A-316A
Present activities:
- NIAID
- Drugs
- Clinical Infectious Diseases
- amFAR Treatment Directory
- AMA-HIV Diagnostic/Therapeutic Technology Assessment Group
- AIDS: Education and Prevention
- AIDS Research and Human Retroviruses
- AIDS Clinical Trials
- U.S. Pharmacopeia and the Merrill Publishing Company
- Journal of Clinical Epidemiology
- JAMA
- JAIDS
- Antiviral Therapy
- American Journal of Obstetrics and Gynecology
- American Journal of Hematology
- XI, XII, XIII, XIV International AIDS Meeting
- The Medical Letter
- Journal of Infectious Diseases
- Journal Acquired Immune Deficiency Syndrome (JAIDS)
Pape, B, E; Para, M, F; Zabik, M J. "Photochemistry of bioactive compounds. Photodecomposition of 2-(1,3-dioxolane-2-yl)-phenyl-N-methyl carbamate.." Journal of agricultural and food chemistry. Vol. 18, no. 3. (January 1970.): 490-3
King, G, W; Para, M, F; LoBuglio, A, F; Sagone, A L Jr. "Human monocyte metabolism: male vs. female.." Journal of the Reticuloendothelial Society. Vol. 17, no. 5. (January 1975.): 282-9
Blackstone, M, O; Dhar, G, J; Mizuno, H; Para, M F. "Gastric sarcoidosis, presenting as antral scarring.." Gastrointestinal endoscopy. Vol. 22, no. 4. (January 1976.): 211-2
Para, M, F; Baucke, R, B; Spear, P G. "Immunoglobulin G(Fc)-binding receptors on virions of herpes simplex virus type 1 and transfer of these receptors to the cell surface by infection.." Journal of virology. Vol. 34, no. 2. (January 1980.): 512-20
Para, M, F; Baucke, R, B; Spear, P G. "Glycoprotein gE of herpes simplex virus type 1: effects of anti-gE on virion infectivity and on virus-induced fc-binding receptors.." Journal of virology. Vol. 41, no. 1. (January 1982.): 129-36
Lee, G, T; Para, M, F; Spear, P G. "Location of the structural genes for glycoproteins gD and gE and for other polypeptides in the S component of herpes simplex virus type 1 DNA.." Journal of virology. Vol. 43, no. 1. (January 1982.): 41-9
Para, M, F; Goldstein, L; Spear, P G. "Similarities and differences in the Fc-binding glycoprotein (gE) of herpes simplex virus types 1 and 2 and tentative mapping of the viral gene for this glycoprotein.." Journal of virology. Vol. 41, no. 1. (January 1982.): 137-44
Para, M, F; Zezulak, K, M; Conley, A, J; Weinberger, M; Snitzer, K; Spear, P G. "Use of monoclonal antibodies against two 75,000-molecular-weight glycoproteins specified by herpes simplex virus type 2 in glycoprotein identification and gene mapping.." Journal of virology. Vol. 45, no. 3. (January 1983.): 1223-7
Para, M, F; Plouffe, J F. "Production of monoclonal antibodies to Legionella pneumophila serogroups 1 and 6.." Journal of clinical microbiology. Vol. 18, no. 4. (January 1983.): 895-900
Maher, W, E; Plouffe, J, F; Para, M F. "Plasmid profiles of clinical and environmental isolates of Legionella pneumophila serogroup 1.." Journal of clinical microbiology. Vol. 18, no. 6. (January 1983.): 1422-3
Plouffe, J, F; Para, M, F; Maher, W, E; Hackman, B; Webster, L. "Subtypes of Legionella pneumophila serogroup 1 associated with different attack rates.." Lancet. Vol. 2, no. 8351. (January 1983.): 649-50
Baker, R, L; Para, M F. "Successful use of ketoconazole for invasive cutaneous Trichophyton rubrum infection.." Archives of internal medicine. Vol. 144, no. 3. (January 1984.): 615-7
Para, MF. "Natural history of herpes simplex virus infections.." Ophthalmology Forum. (October 1984)
Plouffe, J, F; Bollin, G, E; Para, M, F; Kelly, K A. "Serological differences in Legionella pneumophila infections.." Journal of clinical microbiology. Vol. 20, no. 6. (January 1984.): 1223-4
Plouffe, J, F; Para, M, F; Bollin, G E. "Sulfamethoxazole-trimethoprim treatment of guinea pigs infected with Legionella pneumophila.." The Journal of infectious diseases. Vol. 150, no. 5. (January 1984.): 780-2
Cunningham, A, L; Basham, T, Y; Para, M, F; Merigan, T C. "Role of macrophage D-region antigens and T-lymphocyte differentiation antigens in induction of gamma interferon.." Journal of interferon research. Vol. 5, no. 3. (January 1985.): 477-91
Plouffe, J, F; Para, M, F; Fuller, K A. "Serum bactericidal activity against Legionella pneumophila.." Journal of clinical microbiology. Vol. 22, no. 5. (January 1985.): 863-4
Bollin, G, E; Plouffe, J, F; Para, M, F; Prior, R B. "Difference in virulence of environmental isolates of Legionella pneumophila.." Journal of clinical microbiology. Vol. 21, no. 5. (January 1985.): 674-7
Arnow, P, M; Weil, D; Para, M F. "Prevalence and significance of Legionella pneumophila contamination of residential hot-tap water systems.." The Journal of infectious diseases. Vol. 152, no. 1. (January 1985.): 145-51
Para, M, F; Parish, M, L; Noble, A, G; Spear, P G. "Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions.." Journal of virology. Vol. 55, no. 2. (January 1985.): 483-8
Bollin, G, E; Plouffe, J, F; Para, M, F; Hackman, B. "Aerosols containing Legionella pneumophila generated by shower heads and hot-water faucets.." Applied and environmental microbiology. Vol. 50, no. 5. (January 1985.): 1128-31
Cunningham, A, L; Turner, R, R; Miller, A, C; Para, M, F; Merigan, T C. "Evolution of recurrent herpes simplex lesions. An immunohistologic study.." The Journal of clinical investigation. Vol. 75, no. 1. (January 1985.): 226-33
Plouffe, J, F; Para, M, F; Fuller, K A. "Intratracheal infection with L. pneumophila subtypes.." Journal of clinical & laboratory immunology. Vol. 20, no. 3. (January 1986.): 119-20
Plouffe, J, F; Para, M, F; Fuller, K, A; Bollin, G E. "Oral ingestion of Legionella pneumophila.." Journal of clinical & laboratory immunology. Vol. 20, no. 3. (January 1986.): 113-7
Maher, W, E; Para, M, F; Plouffe, J F. "Subtyping of Legionella pneumophila serogroup 1 isolates by monoclonal antibody and plasmid techniques.." Journal of clinical microbiology. Vol. 25, no. 12. (January 1987.): 2281-4
Stout J, Joly J, Plouffe JF , Para MF, Ciesielski C, Blaser M, Yu V. "Comparison of molecular methods for subtyping patient and epidemiologically linked isolates of Legionella pneumophila.." . J Inf Dis. Vol. 157, (January 1988.): 489-495
Strauss, R, H; Leizman, D, J; Lanese, R, R; Para, M F. "Abrasive shirts may contribute to herpes gladiatorum among wrestlers.." The New England journal of medicine. Vol. 320, no. 9. (January 1989.): 598-9
Para MF. "Understanding HIV Infection.." Audio Digest, Internal Medicine. Vol. 37, no. 24. (January 1990)
Fischl, M, A; Richman, D, D; Hansen, N; Collier, A, C; Carey, J, T; Para, M, F; Hardy, W, D; Dolin, R; Powderly, W, G; Allan, J D. "The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.." Annals of internal medicine. Vol. 112, no. 10. (January 1990.): 727-37
Fischl,M,A; Richman,D,D; Hansen,N; Collier,A,C; Carey,J,T; Para,M,F; Hardy,W,D; Dolin,R; Powderly,W,G; Allan,J,D. "The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.." Annals of internal medicine. Vol. 112, no. 10. (May 1990.): 727-737
Williams T, Para M, Crane R, Herwig T. "HIV Infection: The family physician's disease, a seven part series. April through October.." Family Physician. (January 1990)
Herchline, T, E; Plouffe, J, F; Para, M F. "Diabetes mellitus presenting with ketoacidosis following pentamidine therapy in patients with acquired immunodeficiency syndrome.." The Journal of infection. Vol. 22, no. 1. (January 1991.): 41-4
McKnight, P, T; Visconti, J, A; Gower, R, E; Para, M F. "Zidovudine: counseling strategies and compliance.." American pharmacy. Vol. NS31, no. 10. (January 1991.): 38-43
Hershline TE, Para M, Tesi R. "Clinical correlation of cytomegalovirus cultures, serology, and lymphocyte counts following renal transplantation.." Clinical Transplantation. Vol. 5, (January 1991.): 345-350
Haring J, Blozis G, Para MF. "Computer Assisted Instruction - AIDS: Vignettes for Dental Professionals, Four Case Presentations.." Health Sciences Consortium. (January 1991)
Bornstein, R, A; Nasrallah, H, A; Para, M, F; Fass, R, J; Whitacre, C, C; Rice, R R Jr. "Rate of CD4 decline and neuropsychological performance in HIV infection.." Archives of neurology. Vol. 48, no. 7. (January 1991.): 704-7
Bornstein, R, A; Nasrallah, H, A; Para, M, F; Whitacre, C, C; Rosenberger, P; Fass, R, J; Rice, R Jr. "Neuropsychological performance in asymptomatic HIV infection.." The Journal of neuropsychiatry and clinical neurosciences. Vol. 4, no. 4. (January 1992.): 386-94
Bornstein RA, Chakeres D, Brogan M, Nasrallah HA, Fass RJ, Para M, Whitacre C. "Magnetic imaging of white matter lesions in HIV infection.." . J Neuropsychiatry and Clinical Neuroscience. Vol. 4, (January 1992.): 174-178
Sabbaj, S; Para, M, F; Fass, R, J; Adams, P, W; Orosz, C, G; Whitacre, C C. "Quantitation of antigen-specific immune responses in human immunodeficiency virus (HIV)-infected individuals by limiting dilution analysis.." Journal of clinical immunology. Vol. 12, no. 3. (January 1992.): 216-24
Para, M F. "Use of zidovudine following occupational exposure to human immunodeficiency virus.." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. Vol. 15, no. 5. (January 1992.): 884-5
Bornstein, R, A; Nasrallah, H, A; Para, M, F; Whitacre, C, C; Fass, R J. "Change in neuropsychological performance in asymptomatic HIV infection: 1-year follow-up.." AIDS. Vol. 7, no. 12. (January 1993.): 1607-11
Bornstein, R, A; Fama, R; Rosenberger, P; Whitacre, C, C; Para, M, F; Nasrallah, H, A; Fass, R J. "Drug and alcohol use and neuropsychological performance in asymptomatic HIV infection.." The Journal of neuropsychiatry and clinical neurosciences. Vol. 5, no. 3. (January 1993.): 254-9
Bornstein, R, A; Nasrallah, H, A; Para, M, F; Whitacre, C, C; Rosenberger, P; Fass, R J. "Neuropsychological performance in symptomatic and asymptomatic HIV infection.." AIDS. Vol. 7, no. 4. (January 1993.): 519-24
Rosenberger, P, H; Bornstein, R, A; Nasrallah, H, A; Para, M, F; Whitaker, C, C; Fass, R, J; Rice, R R Jr. "Psychopathology in human immunodeficiency virus infection: lifetime and current assessment.." Comprehensive psychiatry. Vol. 34, no. 3. (January 1993.): 150-8
Bornstein, R, A; Pace, P; Rosenberger, P; Nasrallah, H, A; Para, M, F; Whitacre, C, C; Fass, R J. "Depression and neuropsychological performance in asymptomatic HIV infection.." The American journal of psychiatry. Vol. 150, no. 6. (January 1993.): 922-7
Bornstein RA, Podraza AM, Para MF, Whitacre CC, Fass RJ, Rice RR, and Nasrallah HA. "The Role of Minor Head Injury in Neuropsychological Performance in Asymptomatic HIV-1 Infection.." Neuropsychology. Vol. 7, (January 1993.): 228-234
Fletcher, C, V; Collier, A, C; Rhame, F, S; Bennett, D; Para, M, F; Beatty, C, C; Jones, C, E; Balfour, H H Jr. "Foscarnet for suppression of human immunodeficiency virus replication.." Antimicrobial agents and chemotherapy. Vol. 38, no. 3. (January 1994.): 604-7
Bornstein, R, A; Nasrallah, H, A; Para, M, F; Whitacre, C, C; Fass, R J. "Duration of illness and neuropsychological performance in asymptomatic HIV infection.." The Journal of neuropsychiatry and clinical neurosciences. Vol. 6, no. 2. (January 1994.): 160-4
Podraza, A, M; Bornstein, R, A; Whitacre, C, C; Para, M, F; Fass, R, J; Rice, R R Jr; Nasrallah, H A. "Neuropsychological performance and CD4 levels in HIV-1 asymptomatic infection.." Journal of clinical and experimental neuropsychology : official journal of the International Neuropsychological Society. Vol. 16, no. 5. (January 1994.): 777-83
Jacobson,M,A; Wulfsohn,M; Feinberg,J,E; Davis,R; Power,M; Owens,S; Causey,D; HEATHCHIOZZI,M,E; Murphy,R,L; Cheung,T,W; Dieterich,D,T; Spector,S,A; McKinley,G,F; Parenti,D,M; Crumpacker,C; NISHIMOTO,B; Leedom,J,M; Kramer,F; Cohen,C; Loftus,J; KESSLER,H,A; Pottage,J,C; Benson,C,A; Phair,J,P; Gerits,P; Chusid,E; Sacks,H,S; Friedberg,D; CURRANKRIKORIAN,K; Valentine,F,T; Meng,T,C; Freeman,W,R; Meixner,L; Richman,D; ODONNELL,J,J; Kimbrell,C; Boggio,K; Larson,J; Whitmore,P,V; SIMON,G,L; LELACHEUR,S; Fife,K; Zwickl,B; RELUE,J; Steigbigel,R,T; Fuhrer,J; Donlon,W; BURK,R,A; PORTMORE,A,C; WEISSBACH,N,E; HOOTON,T,M; HOLZWORTH,P; Davison,S; Collier,A,C; Powderly,W,G; Klebert,M; Royal,M; Seyfried,W; SQUIRES,K,C; Weiss,W; BARBACCI,M; Becker,R,L; Jabs,D; Bartlett,J,G; Para,M,F; Jones,M; Neidig,J,L; Fass,R,J; VANDERHORST,C; Kylstra,J; Raasch,R; BLOODGOOD,K; Wolitz,R; Kirk,S; Rolfe,L; PATRONEREESE,J; Bartlett,J,A; WASKIN,H,A; Williams,D,K; SHIP,K,W; Kahl,P; ASSAYKEEN,T; Karol,C; MARTINMUNLEY,S; Sumner,P. "PHASE-II DOSE-RANGING TRIAL OF FOSCARNET SALVAGE THERAPY FOR CYTOMEGALOVIRUS RETINITIS IN AIDS PATIENTS INTOLERANT OF OR RESISTANT TO GANCICLOVIR (ACTG PROTOCOL 093)." AIDS. Vol. 8, no. 4. (April 1994.): 451-459
Para, M F. "Antiviral therapy in HIV infection: practical guidelines.." Cleveland Clinic journal of medicine. Vol. 61, no. 1. (January 1994.): 76-7
Reichman,R,C; Morse,G,D; Demeter,L,M; Resnick,L; Bassiakos,Y; Fischl,M; Para,M; Powderly,W; Leedom,J; Greisberger,C. "Phase I study of atevirdine, a nonnucleoside reverse transcriptase inhibitor, in combination with zidovudine for human immunodeficiency virus type 1 infection. ACTG 199 Study Team.." journal of infectious diseases. Vol. 171, no. 2. (February 1995.): 297-304
Dolin R, Amato DA, Fischl MA, Pettinelli C, Beltangady M, Song-heng Liou, Brown M, Cross AP, Hirsch MS, Hardy WD, Mildvan D, Blair DC, Powderly WG, Para MF, Fife KH, Steigbigel RT, Smaldone L.. "Zidovudine compared to didanosine in patients with advanced HIV-1 infection and little or no previous experience with zidovudine.." Arch Intern Med.. Vol. 155, (January 1995.): 961-975
Fischl,M,A; STANLEY,K; Collier,A,C; ARDUINO,J,M; Stein,D,S; Feinberg,J,E; Allan,J,D; Goldsmith,J,C; Powderly,W,G; Raines,C,P; MAYJO,K,J; Keruly,J,C; Craven,D; HIRSHORN,L; Hirsch,M,S; Jayaweera,D,T; Young,S,W; PATRONEREESE,J; Brettler,D; Sperber,K; Gerits,P; Seremetis,S; Gill,J,C; Gelb,L,D; MCGUIRE,M,L; Stiffler,T; Lederman,M,M; Carey,J,T; Wallace,M; MacArthur,R,D; Berge,P; Mildvan,D; Corey,L; COOMBS,R,W; CUMMINGS,D,K; Schooley,R,T; Ray,M,G; WAITE,V; Kuritzkes,D,R; Fuhrer,J; TENZLER,R,J; Donlon,W; VANDERHORST,C,M; Troiani,L; Horton,J; Lane,T,W; Murphy,R,R; Phair,J,P; KESSLER,H,A; Benson,C,A; Rosenwald,V; Yonren,S; Valentine,F; Haslett,P; Mitsuyasu,R,T; Guerro,M; Goetz,M,B; Mathisen,G,E; Frame,P,T; BRINKDOPKE,J; Powell,T; HOELLE,M; Merigan,T,C; Shafer,R; Cain,P; Fessell,J; Henry,K; Rhame,F; Christenson,J; Stryke,D; Zingman,B; Kahl,P; Soeiro,R; Choi, Y, S; REICHMAN,R,L; Reid,J; Blair,D,C; Steigbigel,R,T; Hewitt,R,G; Cameron,M,L; Donnelly,M,A; PACKARD,M,V; Bartlett,J,A; Fife,K,H; ZWICKL,B,W; Borum, J; Burack, J, H; DYBECK,K,A; Coleman,R,L; Johnson,W,R; McKinley,G,F; Grieco,M,H; KOLATCH,B,R; Sepkowitz,K; Ponticello,L; Giordano,M,F; Murray,H,W; GOCKE, D, J; Fass,R,J; Para,M,F; Stern,J,S; Drew, L, J; Spector,S,A; Havlir,D,V; NUFFER,K,L; Richman,D,D; Connor,E,M; Kloser,P,C; PICARDI,J,M; VANMATERMINER,C; Leedom,J,M; Holtom,P,D; Richardson,W; Ehmann,W,C; ZURLO,J,J; Kreher,M; Eyster,M,E; Hyslop,N,E; Mushatt,D,M; Hoadley,D,J; ZACHARY,J,A; SIMON,G,L; Parenti,D,M; LELACHEUR,S; Schuck,S; Ho,M,T; McMahon, D, K; PAZIN,G,J; ROSENER,R; Cheeseman,S,H; MANGINI,L,A; Sands,M,G; Kazial,K; Jones,G; Pettinelli,C,B; Landry,B; Martinez,A,I. "COMBINATION AND MONOTHERAPY WITH ZIDOVUDINE AND ZALCITABINE IN PATIENTS WITH ADVANCED HIV DISEASE." ANNALS OF INTERNAL MEDICINE. Vol. 122, no. 1. (January 1995.): 24-32
Reichman, R, C; Morse, G, D; Demeter, L, M; Resnick, L; Bassiakos, Y; Fischl,M; Para,M; Powderly,W; Leedom,J; Greisberger,C; Nevin,T; Wood,K; Meehan,P,M; GEHEB,H; Cox,S; Batts,D; Timpone,J; Slack,A; Royal,M; QUESADA,N,R; Geiseler,P,J; Stark,N; Neidig,J; Hill,M. "PHASE-I STUDY OF ATEVIRDINE, A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR, IN COMBINATION WITH ZIDOVUDINE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION." JOURNAL OF INFECTIOUS DISEASES. Vol. 171, no. 2. (February 1995.): 297-304
Koletar SL, O'Grady NP, Para MF, Fass RJ. "Cluster of histoplasmosis cases in prisoners with HIV infection.." Infect Dis Clin Prac,. Vol. 4, (January 1995.): 466-468
Reichman RC, Morse GD, Demeter LM, Resnick L, Bassiakos Y, Fischl M, Para MF, Powderly W, Leedom J, Gehab H, Cox S, Batts D, Timpone J.. "Phase I study of atevirdine, a non-nucleoside reverse transcriptase inhibitor given in combination with zidovudine.." . J Infect Dis. Vol. 171, (January 1995.): 297-304
Plouffe,J,F; HERBERT,M,T; File,T,M; Baird,I; Parsons,J,N; Kahn,J,B; RiellyGauvin,K,T; Best,M; Dalieh,S; Fass,R,J; Francis,S; Gray,G; Hackman,B,A; Koletar,S,L; Maher,W,E; Mazur,C; Minor,J; Oglevee,B,A; Para,M,F; PorterfieldBaxa,J; Rogers,T; Saltrom,S,J; Sarokis,M; SCOTTTIBBS,G; Signs,D; Stuart,D; Tan,J; Tumbleson,C,S; Walker,P. "Ofloxacin versus standard therapy in treatment of community-acquired pneumonia requiring hospitalization." ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. Vol. 40, no. 5. (May 1996.): 1175-1179
Plouffe,J,F; Baird,I; Barnishan,J; PorterfieldBaxa,J; Best,M; Dalieh,S; EMERICK,J; Fass,R,J; GIANAKOPOULOS,G; Hackman,B,A; Hadley,S; Herbert,M; Koletar,S,L; Maher,W; Minor,J,A; Oglevee,B,A; Para,M,F; Parsons,J; Rogers,T; SCOTTTIBBS,G; Tumbleson,C,S. "Levofloxacin in vitro activities bacteremic isolates of Streptococcus pneumoniae." DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. Vol. 25, no. 1. (May 1996.): 43-45
Fischl,M,A; Finkelstein,D,M; He,W,L; Powderly,W,G; Triozzi,P,L; Steigbigel,R,T; MAIEWSKI,S; Dale,E; Millar,L; Gould,M; Ratner,L; Para,M,F; Gower,R; Tenzler,R; Fuhrer,J; Mildvan,D; Malamud,S,C; Dezube,B; Chapman,B; Crumpacker,C; ISRAEL,H,B; Feinberg,J; Hood,A; Raines,C,P; Miles,S,A; Mitsuyasu,R,T; Carden,J; McMahon,D; PAZIN,G; Schulof,R,S; Cortless,J,L; LELACHEUR,S,F; Ehmann,W,C; Eyster,M,E; McKinley,G,F; Grieco,M,H; Kolatch,B; Bennett,J,M; Rybak,M,E; Cheeseman,S,H; Koup,R,A; Diamond,A. "A phase II study of recombinant human interferon-(alpha 2a) and zidovudine in patients with AIDS-related Kaposi's sarcoma." JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY. Vol. 11, no. 4. (January 1996.): 379-384
Fischl, M, A; Richman, D, D; Flexner, C; Para, M, F; Haubrich, R; Karim, A; Yeramian, P; Holden-Wiltse, J; Meehan, P M. "Phase I/II study of the toxicity, pharmacokinetics, and activity of the HIV protease inhibitor SC-52151.." Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. Vol. 15, no. 1. (January 1997.): 28-34
Demeter LM, Meehan PM, Morse G, Fischl M, Para M, Powderly W, Leedom J, Holden-Wiltse J, Greisberger C, Wood K, Timpone J, Wathen LK, Resnick L, Batts DH, Reichman RC.. "Phase I Study of atevirdine mesylate (U-87201E) Monotherapy in HIV-1 infected patients.." J Acquir Immune Defic Syndr Hum Retrovirol. Vol. 19, (January 1998.): 135-144
Fehniger TA, Herbein G, Yu H, Para MF, Berstein ZP, O’Brien WA, Caligiuri MA.. "Natural Killer Cells from HIV-1 infected patients produce chemokines and inhibit HIV-1 infection.." J Immunology. Vol. 161, (January 1998.): 6433-6438
Triozzi, P, L; Aldrich, W; Bresler, H, S; Para, M, F; Flancbaum, L J. "Cellular immunotherapy of advanced human immunodeficiency virus type 1 infection using autologous lymph node lymphocytes: effects on chemokine production.." The Journal of infectious diseases. Vol. 179, no. 1. (January 1999.): 245-8
Para, M, F; Meehan, P; Holden-Wiltse, J; Fischl, M; Morse, G; Shafer, R; Demeter, L, M; Wood, K; Nevin, T; Virani-Ketter, N; Freimuth, W W. "ACTG 260: a randomized, phase I-II, dose-ranging trial of the anti-human immunodeficiency virus activity of delavirdine monotherapy. The AIDS Clinical Trials Group Protocol 260 Team.." Antimicrobial agents and chemotherapy. Vol. 43, no. 6. (January 1999.): 1373-8
Morse,G,D; Reichman,R,C; Fischl,M,A; Para,M; Leedom,J; Powderly,W; Demeter,L,M; Resnick,L; Bassiakos,Y; Timpone,J; Cox,S; Batts,D. "Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies." ANTIVIRAL RESEARCH. Vol. 45, no. 1. (January 2000.): 47-58
Katzenstein DA, Hughes M, Albrecht M, Hammer S, Para M, Murphy R, Valdez H, Haubrich R, Liou S.. "Virologic and CD4+ cell responses to new nucleoside regimens: switching to stavudine or adding lamivudine after prolonged zidovudine treatment of human immunodeficiency virus infection. ACTG 302 Study Team. AIDS Clinical Trials Group.." AIDS Res Hum Retroviruses. Vol. 16, (January 2000.): 1031-1037
Morse G, Reichman RC, Fischl M, Para M, Leedom J, Powderly W, Demeter LM, Resnick L, Bassiakos Y, Timpone J, Cox S, Batts D, and the ACTG 187 and 199 Study Teams.. "Concentration-targeted phase I trials of atevirdine mesylate: in patients with HIV.." Antiviral Res. Vol. 45, (January 2000.): 47-58
DeGruttola, V, Dix L, D’Aquila R, Holder D, Phillips A, Ait-Khaled M, Baxter J, Clevenbergh P, Hammer S, Harrigan R, Katzenstein D, Lanier R, Miller M, Para M, Yerly S, Zolopa A, Murray J, Patick A, Miller, Castillo S, Pedneault L, Mellors J.. "The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan.." Antiviral Therapy. Vol. 5, (January 2000.): 41-48
Sevin, A, D; DeGruttola, V; Nijhuis, M; Schapiro, J, M; Foulkes, A, S; Para, M, F; Boucher, C A. "Methods for investigation of the relationship between drug-susceptibility phenotype and human immunodeficiency virus type 1 genotype with applications to AIDS clinical trials group 333.." The Journal of infectious diseases. Vol. 182, no. 1. (January 2000.): 59-67
Demeter, L, M; Shafer, R, W; Meehan, P, M; Holden-Wiltse, J; Fischl, M, A; Freimuth, W, W; Para, M, F; Reichman, R C. "Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260).." Antimicrobial agents and chemotherapy. Vol. 44, no. 3. (January 2000.): 794-7
Albrecht, M, A; Hughes, M, D; Liou, S, H; Katzenstein, D, A; Murphy, R; Balfour, H, H; Para, M, F; Valdez, H; Hammer, S, M; Hammer, S M. "Effect of lamivudine in HIV-infected persons with prior exposure to zidovudine/didanosine or zidovudine/zalcitabine.." AIDS research and human retroviruses. Vol. 16, no. 14. (January 2000.): 1337-44
Para, M, F; Glidden, D, V; Coombs, R, W; Collier, A, C; Condra, J, H; Craig, C; Bassett, R; Leavitt, R; Snyder, S; McAuliffe, V; Boucher, C. "Baseline human immunodeficiency virus type 1 phenotype, genotype, and RNA response after switching from long-term hard-capsule saquinavir to indinavir or soft-gel-capsule saquinavir in AIDS clinical trials group protocol 333.." The Journal of infectious diseases. Vol. 182, no. 3. (January 2000.): 733-43
Para, M, F; Finkelstein, D; Becker, S; Dohn, M; Walawander, A; Black, J R. "Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia: AIDS Clinical Trials Group 268.." Journal of acquired immune deficiency syndromes. Vol. 24, no. 4. (January 2000.): 337-43
Para, M, F; Kalish, L, A; Collier, A, C; Pollard, R, B; Kumar, P, N; Mintz, L; Wallach, F, R; Drew, W, L; Drew, W L. "Qualitative and quantitative PCR measures of cytomegalovirus in patients with advanced HIV infection who require transfusions.." Journal of acquired immune deficiency syndromes. Vol. 26, no. 4. (January 2001.): 320-5
Katzenstein DA, Hughes MD, Albrecht M, Liou SH, Murphy R, Balfour H, Para M, Hammer S. "Virologic and CD4 cell response to zidovudine or zidovudine and lamivudine following didanosine treatment of human immunodeficiency virus infection.." AIDS Res Hum Retroviruses.. Vol. 17, no. 3. (February 2001.): 203-210
Murphy, E, L; Collier, A, C; Kalish, L, A; Assmann, S, F; Para, M, F; Flanigan, T, P; Kumar, P, N; Mintz, L; Wallach, F, R; Nemo, G, J; Nemo, G J. "Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease.." Annals of internal medicine. Vol. 135, no. 1. (January 2001.): 17-26
Para, M, F; Kalish, L, A; Collier, A, C; Murphy, E, L; Drew, W, L; Drew, W L. "Correlates of change in cytomegalovirus viremia in patients with advanced human immunodeficiency virus infection who require transfusion.." The Journal of infectious diseases. Vol. 183, no. 11. (January 2001.): 1673-7
Albrecht, M, A; Bosch, R, J; Hammer, S, M; Liou, S, H; Kessler, H; Para, M, F; Eron, J; Valdez, H; Dehlinger, M; Katzenstein, D, A; Katzenstein, D A. "Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.." The New England journal of medicine. Vol. 345, no. 6. (January 2001.): 398-407
Smith, B, A; Neidig, J, L; Nickel, J, T; Mitchell, G, L; Para, M, F; Fass, R J. "Aerobic exercise: effects on parameters related to fatigue, dyspnea, weight and body composition in HIV-infected adults.." AIDS. Vol. 15, no. 6. (January 2001.): 693-701
Knudtson E, Para M, Boswell H, and Fan-Havard P. "Drug rash, eosinophilia, systemic syndrome and renal toxicity with nevirapine-containing regimen in a pregnant patient with HIV." Obstet Gynecol. Vol. 101, (January 2003.): 1094-1097
Morse, Gene, D; Rosenkranz, Susan; Para, Michael, F; Segal, Yoninah; Difrancesco, Robin; Adams, Elizabeth; Brizz, Barbara; Yarasheski, Kevin, E; Reichman, Richard C. "Amprenavir and efavirenz pharmacokinetics before and after the addition of nelfinavir, indinavir, ritonavir, or saquinavir in seronegative individuals.." Antimicrobial agents and chemotherapy. Vol. 49, no. 8. (January 2005.): 3373-81
Flynn, Neil, M; Forthal, Donald, N; Harro, Clayton, D; Judson, Franklyn, N; Mayer, Kenneth, H; Para, Michael, F; Para, Michael F. "Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.." The Journal of infectious diseases. Vol. 191, no. 5. (January 2005.): 654-65
Joy, Saju; Poi, Ming; Hughes, Laura; Brady, Michael, T; Koletar, Susan, L; Para, Michael, F; Fan-Havard, Patty. "Third-trimester maternal toxicity with nevirapine use in pregnancy.." Obstetrics and gynecology. Vol. 106, no. 5 Pt 1. (January 2005.): 1032-8
Bartholow, Buchbinder S, Celum C, Goli V, Koblin B, Para M, Marmor M, Novak RM, Mayer K, McKirnan DJ, Creticos C, Orozco-Cronin P, Popovic V, and Mastro TD. "For the VISION/VAX004 Study HIV Sexual Risk Behavior over 36-Months of Follow-up in the World’s First HIV Vaccine Efficacy Trial.." BN J Acquir Immune Defic Syndr. Vol. 39, (May 2005.): 90-101
Smith PF, DiCenzo R, Forrest A, Shelton M, Friedland G, Michael F. Para MF, Pollard R, Fischl M, DiFrancesco R, Morse GD.. "Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals." Clinical Pharmacokinet. Vol. 44, (January 2005.): 99-109
Whittington WL, Morris M, Buchbinder SP, McKirnan DJ, Mayer KH, Para MF, Bartholow BN, Celum CL. "Partner-specific sexual behavioral differences between phase 3 HIV vaccine efficacy trial participants and controls: Project VISION.." J Acquir Immune Defic Syndr.. Vol. 43, no. 2. (October 2006.): 234-238
Ma Qing, Forrest A, Rosenkranz S, Para MF, Yarasheski K, Reichman R, Morse G, ACTG 5043 team. "Pharmacokinetic Interactions between efavirenz and dual protease inhibitors.." Biopharmaceutics and Drug Disposition. Vol. 29, no. 2. (January 2007.): 91-101
Rosenkranz SL, Yarasheski KE, Para MF, Reichman R, Morse GD, and the ACTG 5043 Protocol Team. "Antiretroviral drug levels and interactions affect lipid, lipoprotein and glucose metabolism in HIV-1 seronegative subjects: A pharmacokinetic- pharmacodynamic analysis." Metabolic Syndrome and Related Conditions. Vol. 5, no. 2. (January 2007.): 163-173
Okusanya, Olanrewaju; Forrest, Alan; DiFrancesco, Robin; Bilic, Sanela; Rosenkranz, Susan; Para, Michael, F; Adams, Elizabeth; Yarasheski, Kevin, E; Reichman, Richard, C; Morse, Gene, D; Morse, Gene D. "Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks.." Antimicrobial agents and chemotherapy. Vol. 51, no. 5. (January 2007.): 1822-26
Ma Qing, Forrest A, Rosenkranz S, Para MF, Yarasheski K, Reichman R, Morse G, ACTG 5043 team. "Pharmacokinetic interactions between efavirenz and dual protease inhibitors in healthy volunteers.." Biopharaceutics & Druge Disposition. no. 2. (March 2008.): 91-101
Ma,Qing; Forrest,Alan; Rosenkranz,Susan,L; Para,Michael,E; Yarasheski,Kevin,E; Reichman,Richard,C; Morse,Gene,D. "Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers." BIOPHARMACEUTICS & DRUG DISPOSITION. Vol. 29, no. 2. (March 2008.): 91-101
Lalezari J, Yadavalli G, Para M, Richmond G, DeJesus E, Brown R, Cai W, Chen C, Zhon J, Novello L., Lerderman M, Subramanian M.. "Safety, pharmacokinetics and antiviral activity of HGS004, a novel fully human IgG4 monoclonal antibody against CCR5, in HIV-1 infected.." J Infect Dis.. Vol. 197, no. 5. (March 2008.): 721-727
Gust DA, Wiegand RE, Para M, Chen R, Bartholow BN. "HIV testing outside of the study among men who have sex with men participating in an HIV vaccine efficacy trial.." J Acquir Immune Defic Syndr. no. 52. (October 2009.): 290-298
Para MF, Schouten J, Rosenkranz SL, Yu S, Weiner D, Tebas P, White CJ, Reeds D, Lertor J, Patterson K, Daar ES, Cavert W, Brizz B, the ACTG 5200 team.. "Phase I/II Trial of the Anti-HIV Activity of Mifepristone in HIV-infected Subjects ACTG 5200.." J Acquir Immune Defic Syndr. Vol. 53, no. 4. (April 2010.): 491-495
Gandhi R, Bosch RJ, Aga E, Albrecht M, Adams E, Demeter L, Dykes C, Bastow B, Para, M, Si;iciano R, Siliciano J, Eron J, for the ACTG 5173 Team. "No evidence for decay in the latent reservoir in HIV infects patients receiving intensive enfuvirdtide- containing antiretroviral therapy.." Journal of Infectious Diseaes. Vol. 201, no. 2. (January 2010.): 293-296
Wang D, Para MF, Koletar SL, Sadee W.. "Human N-acetyltransferase 1 *10 and *11 alleles increase protein expression through distinct mechanisms and associate with sulfamethoxazole-induced hypersensitivity.." Pharmacogenet Genomics. Vol. 21, no. 10. (October 2011.): 652-664
Kynyk JA, Parsons JP, Para MF, Koletar SL, Diaz PT, Mastronarde JG. "HIV and ASthma, Is there an Association?." Respir Med. Vol. 4, no. 106. (April 2012.): 493-499
Kynyk,Jessica,A; Parsons,Jonathan,P; Para,Michael,F; Koletar,Susan,L; Diaz,Philip,T; Mastronarde,John,G. "HIV and asthma, is there an association?." RESPIRATORY MEDICINE. Vol. 106, no. 4. (April 2012.): 493-499
Wang,Danxin; Curtis,Amanda; Papp,Audrey,C; Koletar,Susan,L; Para,Michael,F. "Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients." BMC MEDICAL GENOMICS. Vol. 5, (July 2012.): 32
Zheng,Lu; Rosenkranz,Susan,L; Taiwo,Babafemi; Para,Michael,F; Eron,Joseph,J; Hughes,Michael,D. "The Design of Single-Arm Clinical Trials of Combination Antiretroviral Regimens for Treatment-Naive HIV-Infected Patients." AIDS RESEARCH AND HUMAN RETROVIRUSES. Vol. 29, no. 4. (April 2013.): 652-657
Zheng S, Eron J, Para M, Taiwo B, Rosencranz S.. "The Design of Single-Arm Clinical Trials of Combination Antiretroviral Regimens for Treatment-Naive HIV Infected Patients"
Wang D, Curtis A, Papp AC, Koletar S, Para MF. "Polymorphism in glutamate cysteine ligase catalytic sybunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients"
King, G, W; Para, M, F; LoBuglio, A, F; Sagone, A L Jr. "Human monocyte metabolism: male vs. female.." Journal of the Reticuloendothelial Society. Vol. 17, no. 5. (January 1975.): 282-9
Blackstone, M, O; Dhar, G, J; Mizuno, H; Para, M F. "Gastric sarcoidosis, presenting as antral scarring.." Gastrointestinal endoscopy. Vol. 22, no. 4. (January 1976.): 211-2
Para, M, F; Baucke, R, B; Spear, P G. "Immunoglobulin G(Fc)-binding receptors on virions of herpes simplex virus type 1 and transfer of these receptors to the cell surface by infection.." Journal of virology. Vol. 34, no. 2. (January 1980.): 512-20
Para, M, F; Baucke, R, B; Spear, P G. "Glycoprotein gE of herpes simplex virus type 1: effects of anti-gE on virion infectivity and on virus-induced fc-binding receptors.." Journal of virology. Vol. 41, no. 1. (January 1982.): 129-36
Lee, G, T; Para, M, F; Spear, P G. "Location of the structural genes for glycoproteins gD and gE and for other polypeptides in the S component of herpes simplex virus type 1 DNA.." Journal of virology. Vol. 43, no. 1. (January 1982.): 41-9
Para, M, F; Goldstein, L; Spear, P G. "Similarities and differences in the Fc-binding glycoprotein (gE) of herpes simplex virus types 1 and 2 and tentative mapping of the viral gene for this glycoprotein.." Journal of virology. Vol. 41, no. 1. (January 1982.): 137-44
Para, M, F; Zezulak, K, M; Conley, A, J; Weinberger, M; Snitzer, K; Spear, P G. "Use of monoclonal antibodies against two 75,000-molecular-weight glycoproteins specified by herpes simplex virus type 2 in glycoprotein identification and gene mapping.." Journal of virology. Vol. 45, no. 3. (January 1983.): 1223-7
Para, M, F; Plouffe, J F. "Production of monoclonal antibodies to Legionella pneumophila serogroups 1 and 6.." Journal of clinical microbiology. Vol. 18, no. 4. (January 1983.): 895-900
Maher, W, E; Plouffe, J, F; Para, M F. "Plasmid profiles of clinical and environmental isolates of Legionella pneumophila serogroup 1.." Journal of clinical microbiology. Vol. 18, no. 6. (January 1983.): 1422-3
Plouffe, J, F; Para, M, F; Maher, W, E; Hackman, B; Webster, L. "Subtypes of Legionella pneumophila serogroup 1 associated with different attack rates.." Lancet. Vol. 2, no. 8351. (January 1983.): 649-50
Baker, R, L; Para, M F. "Successful use of ketoconazole for invasive cutaneous Trichophyton rubrum infection.." Archives of internal medicine. Vol. 144, no. 3. (January 1984.): 615-7
Para, MF. "Natural history of herpes simplex virus infections.." Ophthalmology Forum. (October 1984)
Plouffe, J, F; Bollin, G, E; Para, M, F; Kelly, K A. "Serological differences in Legionella pneumophila infections.." Journal of clinical microbiology. Vol. 20, no. 6. (January 1984.): 1223-4
Plouffe, J, F; Para, M, F; Bollin, G E. "Sulfamethoxazole-trimethoprim treatment of guinea pigs infected with Legionella pneumophila.." The Journal of infectious diseases. Vol. 150, no. 5. (January 1984.): 780-2
Cunningham, A, L; Basham, T, Y; Para, M, F; Merigan, T C. "Role of macrophage D-region antigens and T-lymphocyte differentiation antigens in induction of gamma interferon.." Journal of interferon research. Vol. 5, no. 3. (January 1985.): 477-91
Plouffe, J, F; Para, M, F; Fuller, K A. "Serum bactericidal activity against Legionella pneumophila.." Journal of clinical microbiology. Vol. 22, no. 5. (January 1985.): 863-4
Bollin, G, E; Plouffe, J, F; Para, M, F; Prior, R B. "Difference in virulence of environmental isolates of Legionella pneumophila.." Journal of clinical microbiology. Vol. 21, no. 5. (January 1985.): 674-7
Arnow, P, M; Weil, D; Para, M F. "Prevalence and significance of Legionella pneumophila contamination of residential hot-tap water systems.." The Journal of infectious diseases. Vol. 152, no. 1. (January 1985.): 145-51
Para, M, F; Parish, M, L; Noble, A, G; Spear, P G. "Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions.." Journal of virology. Vol. 55, no. 2. (January 1985.): 483-8
Bollin, G, E; Plouffe, J, F; Para, M, F; Hackman, B. "Aerosols containing Legionella pneumophila generated by shower heads and hot-water faucets.." Applied and environmental microbiology. Vol. 50, no. 5. (January 1985.): 1128-31
Cunningham, A, L; Turner, R, R; Miller, A, C; Para, M, F; Merigan, T C. "Evolution of recurrent herpes simplex lesions. An immunohistologic study.." The Journal of clinical investigation. Vol. 75, no. 1. (January 1985.): 226-33
Plouffe, J, F; Para, M, F; Fuller, K A. "Intratracheal infection with L. pneumophila subtypes.." Journal of clinical & laboratory immunology. Vol. 20, no. 3. (January 1986.): 119-20
Plouffe, J, F; Para, M, F; Fuller, K, A; Bollin, G E. "Oral ingestion of Legionella pneumophila.." Journal of clinical & laboratory immunology. Vol. 20, no. 3. (January 1986.): 113-7
Maher, W, E; Para, M, F; Plouffe, J F. "Subtyping of Legionella pneumophila serogroup 1 isolates by monoclonal antibody and plasmid techniques.." Journal of clinical microbiology. Vol. 25, no. 12. (January 1987.): 2281-4
Stout J, Joly J, Plouffe JF , Para MF, Ciesielski C, Blaser M, Yu V. "Comparison of molecular methods for subtyping patient and epidemiologically linked isolates of Legionella pneumophila.." . J Inf Dis. Vol. 157, (January 1988.): 489-495
Strauss, R, H; Leizman, D, J; Lanese, R, R; Para, M F. "Abrasive shirts may contribute to herpes gladiatorum among wrestlers.." The New England journal of medicine. Vol. 320, no. 9. (January 1989.): 598-9
Para MF. "Understanding HIV Infection.." Audio Digest, Internal Medicine. Vol. 37, no. 24. (January 1990)
Fischl, M, A; Richman, D, D; Hansen, N; Collier, A, C; Carey, J, T; Para, M, F; Hardy, W, D; Dolin, R; Powderly, W, G; Allan, J D. "The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.." Annals of internal medicine. Vol. 112, no. 10. (January 1990.): 727-37
Fischl,M,A; Richman,D,D; Hansen,N; Collier,A,C; Carey,J,T; Para,M,F; Hardy,W,D; Dolin,R; Powderly,W,G; Allan,J,D. "The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.." Annals of internal medicine. Vol. 112, no. 10. (May 1990.): 727-737
Williams T, Para M, Crane R, Herwig T. "HIV Infection: The family physician's disease, a seven part series. April through October.." Family Physician. (January 1990)
Herchline, T, E; Plouffe, J, F; Para, M F. "Diabetes mellitus presenting with ketoacidosis following pentamidine therapy in patients with acquired immunodeficiency syndrome.." The Journal of infection. Vol. 22, no. 1. (January 1991.): 41-4
McKnight, P, T; Visconti, J, A; Gower, R, E; Para, M F. "Zidovudine: counseling strategies and compliance.." American pharmacy. Vol. NS31, no. 10. (January 1991.): 38-43
Hershline TE, Para M, Tesi R. "Clinical correlation of cytomegalovirus cultures, serology, and lymphocyte counts following renal transplantation.." Clinical Transplantation. Vol. 5, (January 1991.): 345-350
Haring J, Blozis G, Para MF. "Computer Assisted Instruction - AIDS: Vignettes for Dental Professionals, Four Case Presentations.." Health Sciences Consortium. (January 1991)
Bornstein, R, A; Nasrallah, H, A; Para, M, F; Fass, R, J; Whitacre, C, C; Rice, R R Jr. "Rate of CD4 decline and neuropsychological performance in HIV infection.." Archives of neurology. Vol. 48, no. 7. (January 1991.): 704-7
Bornstein, R, A; Nasrallah, H, A; Para, M, F; Whitacre, C, C; Rosenberger, P; Fass, R, J; Rice, R Jr. "Neuropsychological performance in asymptomatic HIV infection.." The Journal of neuropsychiatry and clinical neurosciences. Vol. 4, no. 4. (January 1992.): 386-94
Bornstein RA, Chakeres D, Brogan M, Nasrallah HA, Fass RJ, Para M, Whitacre C. "Magnetic imaging of white matter lesions in HIV infection.." . J Neuropsychiatry and Clinical Neuroscience. Vol. 4, (January 1992.): 174-178
Sabbaj, S; Para, M, F; Fass, R, J; Adams, P, W; Orosz, C, G; Whitacre, C C. "Quantitation of antigen-specific immune responses in human immunodeficiency virus (HIV)-infected individuals by limiting dilution analysis.." Journal of clinical immunology. Vol. 12, no. 3. (January 1992.): 216-24
Para, M F. "Use of zidovudine following occupational exposure to human immunodeficiency virus.." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. Vol. 15, no. 5. (January 1992.): 884-5
Bornstein, R, A; Nasrallah, H, A; Para, M, F; Whitacre, C, C; Fass, R J. "Change in neuropsychological performance in asymptomatic HIV infection: 1-year follow-up.." AIDS. Vol. 7, no. 12. (January 1993.): 1607-11
Bornstein, R, A; Fama, R; Rosenberger, P; Whitacre, C, C; Para, M, F; Nasrallah, H, A; Fass, R J. "Drug and alcohol use and neuropsychological performance in asymptomatic HIV infection.." The Journal of neuropsychiatry and clinical neurosciences. Vol. 5, no. 3. (January 1993.): 254-9
Bornstein, R, A; Nasrallah, H, A; Para, M, F; Whitacre, C, C; Rosenberger, P; Fass, R J. "Neuropsychological performance in symptomatic and asymptomatic HIV infection.." AIDS. Vol. 7, no. 4. (January 1993.): 519-24
Rosenberger, P, H; Bornstein, R, A; Nasrallah, H, A; Para, M, F; Whitaker, C, C; Fass, R, J; Rice, R R Jr. "Psychopathology in human immunodeficiency virus infection: lifetime and current assessment.." Comprehensive psychiatry. Vol. 34, no. 3. (January 1993.): 150-8
Bornstein, R, A; Pace, P; Rosenberger, P; Nasrallah, H, A; Para, M, F; Whitacre, C, C; Fass, R J. "Depression and neuropsychological performance in asymptomatic HIV infection.." The American journal of psychiatry. Vol. 150, no. 6. (January 1993.): 922-7
Bornstein RA, Podraza AM, Para MF, Whitacre CC, Fass RJ, Rice RR, and Nasrallah HA. "The Role of Minor Head Injury in Neuropsychological Performance in Asymptomatic HIV-1 Infection.." Neuropsychology. Vol. 7, (January 1993.): 228-234
Fletcher, C, V; Collier, A, C; Rhame, F, S; Bennett, D; Para, M, F; Beatty, C, C; Jones, C, E; Balfour, H H Jr. "Foscarnet for suppression of human immunodeficiency virus replication.." Antimicrobial agents and chemotherapy. Vol. 38, no. 3. (January 1994.): 604-7
Bornstein, R, A; Nasrallah, H, A; Para, M, F; Whitacre, C, C; Fass, R J. "Duration of illness and neuropsychological performance in asymptomatic HIV infection.." The Journal of neuropsychiatry and clinical neurosciences. Vol. 6, no. 2. (January 1994.): 160-4
Podraza, A, M; Bornstein, R, A; Whitacre, C, C; Para, M, F; Fass, R, J; Rice, R R Jr; Nasrallah, H A. "Neuropsychological performance and CD4 levels in HIV-1 asymptomatic infection.." Journal of clinical and experimental neuropsychology : official journal of the International Neuropsychological Society. Vol. 16, no. 5. (January 1994.): 777-83
Jacobson,M,A; Wulfsohn,M; Feinberg,J,E; Davis,R; Power,M; Owens,S; Causey,D; HEATHCHIOZZI,M,E; Murphy,R,L; Cheung,T,W; Dieterich,D,T; Spector,S,A; McKinley,G,F; Parenti,D,M; Crumpacker,C; NISHIMOTO,B; Leedom,J,M; Kramer,F; Cohen,C; Loftus,J; KESSLER,H,A; Pottage,J,C; Benson,C,A; Phair,J,P; Gerits,P; Chusid,E; Sacks,H,S; Friedberg,D; CURRANKRIKORIAN,K; Valentine,F,T; Meng,T,C; Freeman,W,R; Meixner,L; Richman,D; ODONNELL,J,J; Kimbrell,C; Boggio,K; Larson,J; Whitmore,P,V; SIMON,G,L; LELACHEUR,S; Fife,K; Zwickl,B; RELUE,J; Steigbigel,R,T; Fuhrer,J; Donlon,W; BURK,R,A; PORTMORE,A,C; WEISSBACH,N,E; HOOTON,T,M; HOLZWORTH,P; Davison,S; Collier,A,C; Powderly,W,G; Klebert,M; Royal,M; Seyfried,W; SQUIRES,K,C; Weiss,W; BARBACCI,M; Becker,R,L; Jabs,D; Bartlett,J,G; Para,M,F; Jones,M; Neidig,J,L; Fass,R,J; VANDERHORST,C; Kylstra,J; Raasch,R; BLOODGOOD,K; Wolitz,R; Kirk,S; Rolfe,L; PATRONEREESE,J; Bartlett,J,A; WASKIN,H,A; Williams,D,K; SHIP,K,W; Kahl,P; ASSAYKEEN,T; Karol,C; MARTINMUNLEY,S; Sumner,P. "PHASE-II DOSE-RANGING TRIAL OF FOSCARNET SALVAGE THERAPY FOR CYTOMEGALOVIRUS RETINITIS IN AIDS PATIENTS INTOLERANT OF OR RESISTANT TO GANCICLOVIR (ACTG PROTOCOL 093)." AIDS. Vol. 8, no. 4. (April 1994.): 451-459
Para, M F. "Antiviral therapy in HIV infection: practical guidelines.." Cleveland Clinic journal of medicine. Vol. 61, no. 1. (January 1994.): 76-7
Reichman,R,C; Morse,G,D; Demeter,L,M; Resnick,L; Bassiakos,Y; Fischl,M; Para,M; Powderly,W; Leedom,J; Greisberger,C. "Phase I study of atevirdine, a nonnucleoside reverse transcriptase inhibitor, in combination with zidovudine for human immunodeficiency virus type 1 infection. ACTG 199 Study Team.." journal of infectious diseases. Vol. 171, no. 2. (February 1995.): 297-304
Dolin R, Amato DA, Fischl MA, Pettinelli C, Beltangady M, Song-heng Liou, Brown M, Cross AP, Hirsch MS, Hardy WD, Mildvan D, Blair DC, Powderly WG, Para MF, Fife KH, Steigbigel RT, Smaldone L.. "Zidovudine compared to didanosine in patients with advanced HIV-1 infection and little or no previous experience with zidovudine.." Arch Intern Med.. Vol. 155, (January 1995.): 961-975
Fischl,M,A; STANLEY,K; Collier,A,C; ARDUINO,J,M; Stein,D,S; Feinberg,J,E; Allan,J,D; Goldsmith,J,C; Powderly,W,G; Raines,C,P; MAYJO,K,J; Keruly,J,C; Craven,D; HIRSHORN,L; Hirsch,M,S; Jayaweera,D,T; Young,S,W; PATRONEREESE,J; Brettler,D; Sperber,K; Gerits,P; Seremetis,S; Gill,J,C; Gelb,L,D; MCGUIRE,M,L; Stiffler,T; Lederman,M,M; Carey,J,T; Wallace,M; MacArthur,R,D; Berge,P; Mildvan,D; Corey,L; COOMBS,R,W; CUMMINGS,D,K; Schooley,R,T; Ray,M,G; WAITE,V; Kuritzkes,D,R; Fuhrer,J; TENZLER,R,J; Donlon,W; VANDERHORST,C,M; Troiani,L; Horton,J; Lane,T,W; Murphy,R,R; Phair,J,P; KESSLER,H,A; Benson,C,A; Rosenwald,V; Yonren,S; Valentine,F; Haslett,P; Mitsuyasu,R,T; Guerro,M; Goetz,M,B; Mathisen,G,E; Frame,P,T; BRINKDOPKE,J; Powell,T; HOELLE,M; Merigan,T,C; Shafer,R; Cain,P; Fessell,J; Henry,K; Rhame,F; Christenson,J; Stryke,D; Zingman,B; Kahl,P; Soeiro,R; Choi, Y, S; REICHMAN,R,L; Reid,J; Blair,D,C; Steigbigel,R,T; Hewitt,R,G; Cameron,M,L; Donnelly,M,A; PACKARD,M,V; Bartlett,J,A; Fife,K,H; ZWICKL,B,W; Borum, J; Burack, J, H; DYBECK,K,A; Coleman,R,L; Johnson,W,R; McKinley,G,F; Grieco,M,H; KOLATCH,B,R; Sepkowitz,K; Ponticello,L; Giordano,M,F; Murray,H,W; GOCKE, D, J; Fass,R,J; Para,M,F; Stern,J,S; Drew, L, J; Spector,S,A; Havlir,D,V; NUFFER,K,L; Richman,D,D; Connor,E,M; Kloser,P,C; PICARDI,J,M; VANMATERMINER,C; Leedom,J,M; Holtom,P,D; Richardson,W; Ehmann,W,C; ZURLO,J,J; Kreher,M; Eyster,M,E; Hyslop,N,E; Mushatt,D,M; Hoadley,D,J; ZACHARY,J,A; SIMON,G,L; Parenti,D,M; LELACHEUR,S; Schuck,S; Ho,M,T; McMahon, D, K; PAZIN,G,J; ROSENER,R; Cheeseman,S,H; MANGINI,L,A; Sands,M,G; Kazial,K; Jones,G; Pettinelli,C,B; Landry,B; Martinez,A,I. "COMBINATION AND MONOTHERAPY WITH ZIDOVUDINE AND ZALCITABINE IN PATIENTS WITH ADVANCED HIV DISEASE." ANNALS OF INTERNAL MEDICINE. Vol. 122, no. 1. (January 1995.): 24-32
Reichman, R, C; Morse, G, D; Demeter, L, M; Resnick, L; Bassiakos, Y; Fischl,M; Para,M; Powderly,W; Leedom,J; Greisberger,C; Nevin,T; Wood,K; Meehan,P,M; GEHEB,H; Cox,S; Batts,D; Timpone,J; Slack,A; Royal,M; QUESADA,N,R; Geiseler,P,J; Stark,N; Neidig,J; Hill,M. "PHASE-I STUDY OF ATEVIRDINE, A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR, IN COMBINATION WITH ZIDOVUDINE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION." JOURNAL OF INFECTIOUS DISEASES. Vol. 171, no. 2. (February 1995.): 297-304
Koletar SL, O'Grady NP, Para MF, Fass RJ. "Cluster of histoplasmosis cases in prisoners with HIV infection.." Infect Dis Clin Prac,. Vol. 4, (January 1995.): 466-468
Reichman RC, Morse GD, Demeter LM, Resnick L, Bassiakos Y, Fischl M, Para MF, Powderly W, Leedom J, Gehab H, Cox S, Batts D, Timpone J.. "Phase I study of atevirdine, a non-nucleoside reverse transcriptase inhibitor given in combination with zidovudine.." . J Infect Dis. Vol. 171, (January 1995.): 297-304
Plouffe,J,F; HERBERT,M,T; File,T,M; Baird,I; Parsons,J,N; Kahn,J,B; RiellyGauvin,K,T; Best,M; Dalieh,S; Fass,R,J; Francis,S; Gray,G; Hackman,B,A; Koletar,S,L; Maher,W,E; Mazur,C; Minor,J; Oglevee,B,A; Para,M,F; PorterfieldBaxa,J; Rogers,T; Saltrom,S,J; Sarokis,M; SCOTTTIBBS,G; Signs,D; Stuart,D; Tan,J; Tumbleson,C,S; Walker,P. "Ofloxacin versus standard therapy in treatment of community-acquired pneumonia requiring hospitalization." ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. Vol. 40, no. 5. (May 1996.): 1175-1179
Plouffe,J,F; Baird,I; Barnishan,J; PorterfieldBaxa,J; Best,M; Dalieh,S; EMERICK,J; Fass,R,J; GIANAKOPOULOS,G; Hackman,B,A; Hadley,S; Herbert,M; Koletar,S,L; Maher,W; Minor,J,A; Oglevee,B,A; Para,M,F; Parsons,J; Rogers,T; SCOTTTIBBS,G; Tumbleson,C,S. "Levofloxacin in vitro activities bacteremic isolates of Streptococcus pneumoniae." DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. Vol. 25, no. 1. (May 1996.): 43-45
Fischl,M,A; Finkelstein,D,M; He,W,L; Powderly,W,G; Triozzi,P,L; Steigbigel,R,T; MAIEWSKI,S; Dale,E; Millar,L; Gould,M; Ratner,L; Para,M,F; Gower,R; Tenzler,R; Fuhrer,J; Mildvan,D; Malamud,S,C; Dezube,B; Chapman,B; Crumpacker,C; ISRAEL,H,B; Feinberg,J; Hood,A; Raines,C,P; Miles,S,A; Mitsuyasu,R,T; Carden,J; McMahon,D; PAZIN,G; Schulof,R,S; Cortless,J,L; LELACHEUR,S,F; Ehmann,W,C; Eyster,M,E; McKinley,G,F; Grieco,M,H; Kolatch,B; Bennett,J,M; Rybak,M,E; Cheeseman,S,H; Koup,R,A; Diamond,A. "A phase II study of recombinant human interferon-(alpha 2a) and zidovudine in patients with AIDS-related Kaposi's sarcoma." JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY. Vol. 11, no. 4. (January 1996.): 379-384
Fischl, M, A; Richman, D, D; Flexner, C; Para, M, F; Haubrich, R; Karim, A; Yeramian, P; Holden-Wiltse, J; Meehan, P M. "Phase I/II study of the toxicity, pharmacokinetics, and activity of the HIV protease inhibitor SC-52151.." Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. Vol. 15, no. 1. (January 1997.): 28-34
Demeter LM, Meehan PM, Morse G, Fischl M, Para M, Powderly W, Leedom J, Holden-Wiltse J, Greisberger C, Wood K, Timpone J, Wathen LK, Resnick L, Batts DH, Reichman RC.. "Phase I Study of atevirdine mesylate (U-87201E) Monotherapy in HIV-1 infected patients.." J Acquir Immune Defic Syndr Hum Retrovirol. Vol. 19, (January 1998.): 135-144
Fehniger TA, Herbein G, Yu H, Para MF, Berstein ZP, O’Brien WA, Caligiuri MA.. "Natural Killer Cells from HIV-1 infected patients produce chemokines and inhibit HIV-1 infection.." J Immunology. Vol. 161, (January 1998.): 6433-6438
Triozzi, P, L; Aldrich, W; Bresler, H, S; Para, M, F; Flancbaum, L J. "Cellular immunotherapy of advanced human immunodeficiency virus type 1 infection using autologous lymph node lymphocytes: effects on chemokine production.." The Journal of infectious diseases. Vol. 179, no. 1. (January 1999.): 245-8
Para, M, F; Meehan, P; Holden-Wiltse, J; Fischl, M; Morse, G; Shafer, R; Demeter, L, M; Wood, K; Nevin, T; Virani-Ketter, N; Freimuth, W W. "ACTG 260: a randomized, phase I-II, dose-ranging trial of the anti-human immunodeficiency virus activity of delavirdine monotherapy. The AIDS Clinical Trials Group Protocol 260 Team.." Antimicrobial agents and chemotherapy. Vol. 43, no. 6. (January 1999.): 1373-8
Morse,G,D; Reichman,R,C; Fischl,M,A; Para,M; Leedom,J; Powderly,W; Demeter,L,M; Resnick,L; Bassiakos,Y; Timpone,J; Cox,S; Batts,D. "Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies." ANTIVIRAL RESEARCH. Vol. 45, no. 1. (January 2000.): 47-58
Katzenstein DA, Hughes M, Albrecht M, Hammer S, Para M, Murphy R, Valdez H, Haubrich R, Liou S.. "Virologic and CD4+ cell responses to new nucleoside regimens: switching to stavudine or adding lamivudine after prolonged zidovudine treatment of human immunodeficiency virus infection. ACTG 302 Study Team. AIDS Clinical Trials Group.." AIDS Res Hum Retroviruses. Vol. 16, (January 2000.): 1031-1037
Morse G, Reichman RC, Fischl M, Para M, Leedom J, Powderly W, Demeter LM, Resnick L, Bassiakos Y, Timpone J, Cox S, Batts D, and the ACTG 187 and 199 Study Teams.. "Concentration-targeted phase I trials of atevirdine mesylate: in patients with HIV.." Antiviral Res. Vol. 45, (January 2000.): 47-58
DeGruttola, V, Dix L, D’Aquila R, Holder D, Phillips A, Ait-Khaled M, Baxter J, Clevenbergh P, Hammer S, Harrigan R, Katzenstein D, Lanier R, Miller M, Para M, Yerly S, Zolopa A, Murray J, Patick A, Miller, Castillo S, Pedneault L, Mellors J.. "The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan.." Antiviral Therapy. Vol. 5, (January 2000.): 41-48
Sevin, A, D; DeGruttola, V; Nijhuis, M; Schapiro, J, M; Foulkes, A, S; Para, M, F; Boucher, C A. "Methods for investigation of the relationship between drug-susceptibility phenotype and human immunodeficiency virus type 1 genotype with applications to AIDS clinical trials group 333.." The Journal of infectious diseases. Vol. 182, no. 1. (January 2000.): 59-67
Demeter, L, M; Shafer, R, W; Meehan, P, M; Holden-Wiltse, J; Fischl, M, A; Freimuth, W, W; Para, M, F; Reichman, R C. "Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260).." Antimicrobial agents and chemotherapy. Vol. 44, no. 3. (January 2000.): 794-7
Albrecht, M, A; Hughes, M, D; Liou, S, H; Katzenstein, D, A; Murphy, R; Balfour, H, H; Para, M, F; Valdez, H; Hammer, S, M; Hammer, S M. "Effect of lamivudine in HIV-infected persons with prior exposure to zidovudine/didanosine or zidovudine/zalcitabine.." AIDS research and human retroviruses. Vol. 16, no. 14. (January 2000.): 1337-44
Para, M, F; Glidden, D, V; Coombs, R, W; Collier, A, C; Condra, J, H; Craig, C; Bassett, R; Leavitt, R; Snyder, S; McAuliffe, V; Boucher, C. "Baseline human immunodeficiency virus type 1 phenotype, genotype, and RNA response after switching from long-term hard-capsule saquinavir to indinavir or soft-gel-capsule saquinavir in AIDS clinical trials group protocol 333.." The Journal of infectious diseases. Vol. 182, no. 3. (January 2000.): 733-43
Para, M, F; Finkelstein, D; Becker, S; Dohn, M; Walawander, A; Black, J R. "Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia: AIDS Clinical Trials Group 268.." Journal of acquired immune deficiency syndromes. Vol. 24, no. 4. (January 2000.): 337-43
Para, M, F; Kalish, L, A; Collier, A, C; Pollard, R, B; Kumar, P, N; Mintz, L; Wallach, F, R; Drew, W, L; Drew, W L. "Qualitative and quantitative PCR measures of cytomegalovirus in patients with advanced HIV infection who require transfusions.." Journal of acquired immune deficiency syndromes. Vol. 26, no. 4. (January 2001.): 320-5
Katzenstein DA, Hughes MD, Albrecht M, Liou SH, Murphy R, Balfour H, Para M, Hammer S. "Virologic and CD4 cell response to zidovudine or zidovudine and lamivudine following didanosine treatment of human immunodeficiency virus infection.." AIDS Res Hum Retroviruses.. Vol. 17, no. 3. (February 2001.): 203-210
Murphy, E, L; Collier, A, C; Kalish, L, A; Assmann, S, F; Para, M, F; Flanigan, T, P; Kumar, P, N; Mintz, L; Wallach, F, R; Nemo, G, J; Nemo, G J. "Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease.." Annals of internal medicine. Vol. 135, no. 1. (January 2001.): 17-26
Para, M, F; Kalish, L, A; Collier, A, C; Murphy, E, L; Drew, W, L; Drew, W L. "Correlates of change in cytomegalovirus viremia in patients with advanced human immunodeficiency virus infection who require transfusion.." The Journal of infectious diseases. Vol. 183, no. 11. (January 2001.): 1673-7
Albrecht, M, A; Bosch, R, J; Hammer, S, M; Liou, S, H; Kessler, H; Para, M, F; Eron, J; Valdez, H; Dehlinger, M; Katzenstein, D, A; Katzenstein, D A. "Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.." The New England journal of medicine. Vol. 345, no. 6. (January 2001.): 398-407
Smith, B, A; Neidig, J, L; Nickel, J, T; Mitchell, G, L; Para, M, F; Fass, R J. "Aerobic exercise: effects on parameters related to fatigue, dyspnea, weight and body composition in HIV-infected adults.." AIDS. Vol. 15, no. 6. (January 2001.): 693-701
Knudtson E, Para M, Boswell H, and Fan-Havard P. "Drug rash, eosinophilia, systemic syndrome and renal toxicity with nevirapine-containing regimen in a pregnant patient with HIV." Obstet Gynecol. Vol. 101, (January 2003.): 1094-1097
Morse, Gene, D; Rosenkranz, Susan; Para, Michael, F; Segal, Yoninah; Difrancesco, Robin; Adams, Elizabeth; Brizz, Barbara; Yarasheski, Kevin, E; Reichman, Richard C. "Amprenavir and efavirenz pharmacokinetics before and after the addition of nelfinavir, indinavir, ritonavir, or saquinavir in seronegative individuals.." Antimicrobial agents and chemotherapy. Vol. 49, no. 8. (January 2005.): 3373-81
Flynn, Neil, M; Forthal, Donald, N; Harro, Clayton, D; Judson, Franklyn, N; Mayer, Kenneth, H; Para, Michael, F; Para, Michael F. "Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.." The Journal of infectious diseases. Vol. 191, no. 5. (January 2005.): 654-65
Joy, Saju; Poi, Ming; Hughes, Laura; Brady, Michael, T; Koletar, Susan, L; Para, Michael, F; Fan-Havard, Patty. "Third-trimester maternal toxicity with nevirapine use in pregnancy.." Obstetrics and gynecology. Vol. 106, no. 5 Pt 1. (January 2005.): 1032-8
Bartholow, Buchbinder S, Celum C, Goli V, Koblin B, Para M, Marmor M, Novak RM, Mayer K, McKirnan DJ, Creticos C, Orozco-Cronin P, Popovic V, and Mastro TD. "For the VISION/VAX004 Study HIV Sexual Risk Behavior over 36-Months of Follow-up in the World’s First HIV Vaccine Efficacy Trial.." BN J Acquir Immune Defic Syndr. Vol. 39, (May 2005.): 90-101
Smith PF, DiCenzo R, Forrest A, Shelton M, Friedland G, Michael F. Para MF, Pollard R, Fischl M, DiFrancesco R, Morse GD.. "Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals." Clinical Pharmacokinet. Vol. 44, (January 2005.): 99-109
Whittington WL, Morris M, Buchbinder SP, McKirnan DJ, Mayer KH, Para MF, Bartholow BN, Celum CL. "Partner-specific sexual behavioral differences between phase 3 HIV vaccine efficacy trial participants and controls: Project VISION.." J Acquir Immune Defic Syndr.. Vol. 43, no. 2. (October 2006.): 234-238
Ma Qing, Forrest A, Rosenkranz S, Para MF, Yarasheski K, Reichman R, Morse G, ACTG 5043 team. "Pharmacokinetic Interactions between efavirenz and dual protease inhibitors.." Biopharmaceutics and Drug Disposition. Vol. 29, no. 2. (January 2007.): 91-101
Rosenkranz SL, Yarasheski KE, Para MF, Reichman R, Morse GD, and the ACTG 5043 Protocol Team. "Antiretroviral drug levels and interactions affect lipid, lipoprotein and glucose metabolism in HIV-1 seronegative subjects: A pharmacokinetic- pharmacodynamic analysis." Metabolic Syndrome and Related Conditions. Vol. 5, no. 2. (January 2007.): 163-173
Okusanya, Olanrewaju; Forrest, Alan; DiFrancesco, Robin; Bilic, Sanela; Rosenkranz, Susan; Para, Michael, F; Adams, Elizabeth; Yarasheski, Kevin, E; Reichman, Richard, C; Morse, Gene, D; Morse, Gene D. "Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks.." Antimicrobial agents and chemotherapy. Vol. 51, no. 5. (January 2007.): 1822-26
Ma Qing, Forrest A, Rosenkranz S, Para MF, Yarasheski K, Reichman R, Morse G, ACTG 5043 team. "Pharmacokinetic interactions between efavirenz and dual protease inhibitors in healthy volunteers.." Biopharaceutics & Druge Disposition. no. 2. (March 2008.): 91-101
Ma,Qing; Forrest,Alan; Rosenkranz,Susan,L; Para,Michael,E; Yarasheski,Kevin,E; Reichman,Richard,C; Morse,Gene,D. "Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers." BIOPHARMACEUTICS & DRUG DISPOSITION. Vol. 29, no. 2. (March 2008.): 91-101
Lalezari J, Yadavalli G, Para M, Richmond G, DeJesus E, Brown R, Cai W, Chen C, Zhon J, Novello L., Lerderman M, Subramanian M.. "Safety, pharmacokinetics and antiviral activity of HGS004, a novel fully human IgG4 monoclonal antibody against CCR5, in HIV-1 infected.." J Infect Dis.. Vol. 197, no. 5. (March 2008.): 721-727
Gust DA, Wiegand RE, Para M, Chen R, Bartholow BN. "HIV testing outside of the study among men who have sex with men participating in an HIV vaccine efficacy trial.." J Acquir Immune Defic Syndr. no. 52. (October 2009.): 290-298
Para MF, Schouten J, Rosenkranz SL, Yu S, Weiner D, Tebas P, White CJ, Reeds D, Lertor J, Patterson K, Daar ES, Cavert W, Brizz B, the ACTG 5200 team.. "Phase I/II Trial of the Anti-HIV Activity of Mifepristone in HIV-infected Subjects ACTG 5200.." J Acquir Immune Defic Syndr. Vol. 53, no. 4. (April 2010.): 491-495
Gandhi R, Bosch RJ, Aga E, Albrecht M, Adams E, Demeter L, Dykes C, Bastow B, Para, M, Si;iciano R, Siliciano J, Eron J, for the ACTG 5173 Team. "No evidence for decay in the latent reservoir in HIV infects patients receiving intensive enfuvirdtide- containing antiretroviral therapy.." Journal of Infectious Diseaes. Vol. 201, no. 2. (January 2010.): 293-296
Wang D, Para MF, Koletar SL, Sadee W.. "Human N-acetyltransferase 1 *10 and *11 alleles increase protein expression through distinct mechanisms and associate with sulfamethoxazole-induced hypersensitivity.." Pharmacogenet Genomics. Vol. 21, no. 10. (October 2011.): 652-664
Kynyk JA, Parsons JP, Para MF, Koletar SL, Diaz PT, Mastronarde JG. "HIV and ASthma, Is there an Association?." Respir Med. Vol. 4, no. 106. (April 2012.): 493-499
Kynyk,Jessica,A; Parsons,Jonathan,P; Para,Michael,F; Koletar,Susan,L; Diaz,Philip,T; Mastronarde,John,G. "HIV and asthma, is there an association?." RESPIRATORY MEDICINE. Vol. 106, no. 4. (April 2012.): 493-499
Wang,Danxin; Curtis,Amanda; Papp,Audrey,C; Koletar,Susan,L; Para,Michael,F. "Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients." BMC MEDICAL GENOMICS. Vol. 5, (July 2012.): 32
Zheng,Lu; Rosenkranz,Susan,L; Taiwo,Babafemi; Para,Michael,F; Eron,Joseph,J; Hughes,Michael,D. "The Design of Single-Arm Clinical Trials of Combination Antiretroviral Regimens for Treatment-Naive HIV-Infected Patients." AIDS RESEARCH AND HUMAN RETROVIRUSES. Vol. 29, no. 4. (April 2013.): 652-657
Zheng S, Eron J, Para M, Taiwo B, Rosencranz S.. "The Design of Single-Arm Clinical Trials of Combination Antiretroviral Regimens for Treatment-Naive HIV Infected Patients"
Wang D, Curtis A, Papp AC, Koletar S, Para MF. "Polymorphism in glutamate cysteine ligase catalytic sybunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients"